Sanegene Bio
Founded 2021 · 33 employees on LinkedIn · 2 known investors
Find your way into Sanegene Bio
134 people in our graph share verified history with the Sanegene Bio team — schools, employers, funds. One of them is your warm intro.
Kelly Donovanunlockedknows Shiyu Wang · together at Penn State University (overlapped)
×10knows the team · via Penn State University
knows the team · via University of Michigan Medical School
SanegeneBio is a biotech company developing RNA interference (RNAi) genetic medicines for obesity, cardiometabolic, and autoimmune diseases. Its LEAD (Ligand and Enhancer Assisted Delivery) platform enables tissue-specific gene silencing in the liver, adipose tissue, muscle, and immune cells via subcutaneous dosing.
Founders & leadership
Sanegene Bio was founded in 2021 by Shiyu Wang.
SW
Shiyu WanginCo-founder and CSOShiyu Wang is a research scientist with over six years of experience in liver biology and preclinical drug discovery. With training in biochemistry, he has expertise in in vitro and in vivo pharmacology, assay development, and antisense oligonucleotide therapeutics.
Investors · 2
Competitors · 3
by search overlap
Day One Biopharmaceuticals36 shared keywordsDay One is a biopharmaceutical company that develops first- or best-in-class targeted medicines for children and adults with life-threatening diseases, with a focus on cancers such as pediatric brain tumors. Founded in 2018, it received its first FDA approval in 2024 for a pediatric brain tumor treatment.
Bioworld35 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Sana Biotechnology34 shared keywordsSana is a biotech company developing engineered cell medicines, including gene therapies for gene modification and delivery, cell replacement therapies using stem cell biology, and manufacturing solutions to improve patient access to these treatments.
Companies competing with Sanegene Bio for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Sanegene Bio do?
- SanegeneBio is a biotech company developing RNA interference (RNAi) genetic medicines for obesity, cardiometabolic, and autoimmune diseases. Its LEAD (Ligand and Enhancer Assisted Delivery) platform enables tissue-specific gene silencing in the liver, adipose tissue, muscle, and immune cells via subcutaneous dosing.
- Who founded Sanegene Bio?
- Sanegene Bio was founded by Shiyu Wang in 2021.
- Who are Sanegene Bio's investors?
- Sanegene Bio's investors include Qiming Venture Partners, Vivo Capital.